Cargando…

Improving the efficiency of cost-effectiveness analysis to inform policy decisions in the real world: lessons from the Pharmacoeconomics Research Unit at Cancer Care Ontario

Detalles Bibliográficos
Autor principal:	Hoch, Jeffrey S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123048/ http://dx.doi.org/10.1186/1472-6963-14-S2-O39

Ejemplares similares

Pharmacoeconomics in COPD: lessons for the future
por: Starkie, Helen J, et al.
Publicado: (2008)

Drug Policy Research & Pharmacoeconomics
Publicado: (2008)

Antibiotic pharmacoeconomics: an attempt to find the real cost of hospital antibiotic prescribing.
por: Kerr, J. R., et al.
Publicado: (1993)

S312: IS BREXUCABTAGENE AUTOLEUCEL A COST-EFFECTIVE TREATMENT FOR REFRACTORY/RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA? A PHARMACOECONOMIC ANALYSIS IN THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM.
por: Marchetti, Monia
Publicado: (2023)

Bridging the Gap Between Pharmacoeconomics and the Real-World Practice of Managed Care Pharmacy
por: Shaya, Fadia T., et al.
Publicado: (2007)

Adapting Pharmacoeconomics to Shape Efficient Health Systems en Route to UHC – Lessons from Two Continents
por: Miot, Jacqui, et al.
Publicado: (2017)

Modelling cost-effectiveness and value of information in clinical trials to inform stop go decisions: results from the arctic study
por: Smith, Alison, et al.
Publicado: (2015)

Molecular-based allergy diagnostics in the real world: evidence for a cost explosion and an impact vacuum
por: Conlon, Niall, et al.
Publicado: (2015)

Pharmacoeconomics - Determiniation of the Cost-Effectiveness of Helicobacter Pylori Eradication
por: Curtiss, Frederic R.
Publicado: (2003)

Essentials of pharmacoeconomics
por: Rascati, Karen L.
Publicado: (2014)

Principles of pharmacoeconomics /
Publicado: (1996)

Pharmacoeconomics of genotyping-based treatment decisions in patients with chronic pain
por: Morlock, Robert, et al.
Publicado: (2017)

On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
por: Carta, Andrea, et al.
Publicado: (2020)

CBT-E informed practice in an adult outpatient service: How effective is it in a real world setting?
por: Ryan, Lara, et al.
Publicado: (2015)

Real-World Cost-Effectiveness Analysis: How Much Uncertainty Is in the Results?
por: Barr, Heather K., et al.
Publicado: (2023)

Accuracy in Pharmacoeconomic Literature Review: Lessons Learned From the Navajo Code Talkers
por: Fairman, Kathleen A.
Publicado: (2008)

Rapid Review of Real-World Cost-Effectiveness Analyses of Cancer Interventions in Canada
por: Guggenbickler, Andrea M., et al.
Publicado: (2022)

Pharmacoeconomic evaluation of costs of rheumatoid arthritis therapy with selected biological treatment
por: Kowalik, Krzysztof, et al.
Publicado: (2018)

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer
por: Mittmann, Nicole, et al.
Publicado: (2022)

Phase-specific and lifetime costs of cancer care in Ontario, Canada
por: de Oliveira, Claire, et al.
Publicado: (2016)

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?
por: Davari, Majid
Publicado: (2012)

Efficacy, Safety, and Pharmacoeconomic Analysis of Adalimumab and Secukinumab for Moderate-to-Severe Plaque Psoriasis: A Single-Center, Real-World Study
por: Li, Gaojie, et al.
Publicado: (2022)

Fluid management: the pharmacoeconomic dimension
por: Vincent, Jean-Louis
Publicado: (2000)

Development of pharmacoeconomics guidelines for India
por: Thomas, Dixon, et al.
Publicado: (2014)

Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003)

Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007)

Cost analysis of UMMC services: estimating the unit cost for outpatient and inpatient services
por: Dahlui, Maznah, et al.
Publicado: (2012)

Dissemination of Cost Action FP0905 information by website
por: Migliacci, Fabio, et al.
Publicado: (2011)

Pharmacoeconomic Analysis of Heartworm Preventive Compliance and Revenue in Veterinary Practices in the United States
por: Mwacalimba, Kennedy, et al.
Publicado: (2021)

26. Risk of Post–COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021)

A Pharmacoeconomic Outlook of the Biological Drugs Marketed in India: A Cost Variance Analysis
por: Shinde, Viraj A, et al.
Publicado: (2023)

Determinants of Health Management Information Systems performance: lessons from a district level assessment
por: Mishra, Amit, et al.
Publicado: (2012)

Pharmacoeconomic considerations in the treatment of breast cancer
por: Pallis, Athanasios, et al.
Publicado: (2010)

Grand Challenges in Pharmacoeconomics and Health Outcomes
por: Dubois, Dominique J.
Publicado: (2010)

Pharmacoeconomics guidelines: The need of hour for India
por: Oberoi, Sukhvinder Singh, et al.
Publicado: (2014)

Pharmacoeconomic studies in Nepal: the need of the hour
por: Acharya, Mahip
Publicado: (2014)

Pharmacoeconomic evaluations in the treatment of actinic keratoses
por: Tolley, Keith, et al.
Publicado: (2017)

Systematic review of pharmacoeconomic models for schizophrenia
por: Zhou, Junwen, et al.
Publicado: (2018)

Pharmacoeconomics in Africa: needs, prospect and challenges
por: Ben-Ajepe, Temitope, et al.
Publicado: (2021)

CHEERS to 30 Years of PharmacoEconomics
por: Milne, Richard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjflrkhlp5iierhct8hg3p5ptf